A Study to Investigate Safety, Tolerability, and Pharmacokinetics (PK) of VH4524184 and the Potential for Changes in Cytochrome P450 3A (CYP3A) Activity
Clinical trial NCT05631704 · COMPLETED
Trial details
- NCT number
- NCT05631704
- Sponsor
- ViiV Healthcare
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-02
- Primary completion
- 2023-07-27
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.